Back to Journals » Drug Design, Development and Therapy » Volume 15

Consolidation Treatment and Long-Term Prognosis of Rituximab in Minimal Change Disease and Focal Segmental Glomerular Sclerosis

Total article views   HTML views PDF downloads Totals
6,402 Dovepress* 5,613+ 536 6,149
PubMed Central* 789 394 1,183
Totals 6,402 930 7,332
*Since 10 May 2021

View citations on PubMed Central and Google Scholar